Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
SonoThera develops ultrasound-based technologies for delivering genetic therapies to targeted tissues.
Countable Labs provides a PCR system for single-molecule counting and high-sensitivity molecular detection in biotechnology.
Prometheus is an artificial-intelligence company that builds systems for the physical economy.
Boundless Bio is a precision oncology company that develops therapeutics directed against extrachromosomal DNA in aggressive cancers.
Sana Biotechnology is a developer of engineered cells intended to be used as medicine for patients.
CREATE Medicines is a biotech company developing in vivo CAR therapies using mRNA-LNP immune cell programming technology.
Quantum Circuits is delivering a full-stack quantum computer based on the innovative dual-rail qubit providing superior performance.
Proof Diagnostics is a health technology company that develops a diagnostic test for the detection of coronavirus disease infection.
Moleculent is the Biotechnology Research company.
Orbital Therapeutics is a biotechnology company that develops RNA-based medicines to treat disease in humans.
Pheast Therapeutics develops checkpoint therapies to harness the innate immune system.
Neumora Therapeutics operates as a clinical-stage biotechnology company.
Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence.
Maze Therapeutics is a biotechnology company that develops precision medicines for renal, cardiovascular, and metabolic diseases.
CERo Therapeutics, Inc. is a new cellular immunotherapy company.
Lightcast uses a microfluidic platform to make advances towards unique clinical approaches, new therapies, and innovative products.
AIRNA develops RNA editing technologies to create medicines for various diseases.
Atlas Data Storage is an information technology company focused on data storage solutions.
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Seaport Therapeutics is a clinical-stage biopharmaceutical company that develops neuropsychiatric medicines.
Jaguar Gene Therapy is accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases.
LifeMine Therapeutics combines genomics with AI and synthetic biology to discover and develop a pipeline of novel medicines.
Arbor Biotechnologies is a biotechnology company specializing in next-generation gene editing therapeutics to treat genetic diseases.
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
ARCH Venture Partners has invested in 236 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
ARCH Venture Partners's top investment sectors include Biotechnology, Therapeutics, Life Science, Health Care, Biopharma. The firm invests across 29 different industry categories.
Among tracked funding rounds, Xaira Therapeutics received $1.0B in a Series A round. ARCH Venture Partners's total known invested capital is $28.0B.
ARCH Venture Partners's average investment size is $123.2M across its portfolio of 236 companies.
Recent ARCH Venture Partners portfolio additions include SonoThera, Countable Labs, Prometheus, Boundless Bio, Sana Biotechnology. These companies were founded in 2020 or later.